معرفی
Professor Neil Vargesson is a Chair in Developmental Biology at the University of Aberdeen, leading the Theme of Molecular and Cellular Function in the Institute of Medical Sciences. He holds academic roles including Fellowships with the Royal Society of Edinburgh (FRSE), Royal Society of Biology (FRSB), and Higher Education Academy (FHEA). His research focuses on developmental biology, teratogenesis, and drug safety, particularly studying thalidomide and Primodos-induced birth defects. He advises international governments and agencies, including the World Health Organization and Canadian Parliament, and contributes to policy reviews on drug safety. Vargesson has received the 2017 University of Aberdeen Principal's Prize for Public Engagement with Research.
Education:
- Ph.D. (Developmental Biology), University College London, 1998
- B.Sc. (Hons) Human Biology, King's College London, 1994
- CASLAT (Certificate of Advanced Study in Learning and Teaching), Imperial College London, 2005
- ILM Level 5 Certificate in Leadership and Management, University of Aberdeen, 2021
Research Interests:
Professor Vargesson investigates mechanisms of embryonic development and teratogenesis, particularly how drugs like thalidomide and Primodos cause congenital defects. His work includes developing safer drug alternatives, studying vascular dysgenesis, and exploring YAP signaling pathways. He collaborates internationally, contributing to policy changes and survivor compensation programs in Canada, Australia, and Malta. His research bridges basic science with public engagement, addressing ethical and societal impacts of drug development.
Grants & Funding:
- Wellcome Trust/NIH-funded PhD Scholar program (2012–2016)
- Sarcoma UK Project Grant (2015–2017)
Awards & Recognition:
- 2017 Principal's Prize for Public Engagement
- Member, Canadian Thalidomide Survivors Support Program’s Multi-Disciplinary Committee
Labs & Teams: Leads research teams in developmental biology and molecular cellular function, collaborating with institutions globally. His lab utilizes chicken and zebrafish embryo models to study drug effects and developmental pathways.
